RVMD position history
The shares of Revolution Medicines (RVMD) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 209,731 shares, $5.8M, 1.5% of portfolio
- 2021 Q4: 212,231 shares, $5.3M, 1.3% of portfolio, Add +1.2%
- 2022 Q1: 232,101 shares, $5.9M, 1.5% of portfolio, Add +9.4%
- 2022 Q2: 299,785 shares, $5.8M, 1.6% of portfolio, Add +29.2%
- 2022 Q3: 479,785 shares, $9.5M, 2.5% of portfolio, Add +60.0%
- 2022 Q4: 477,785 shares, $11M, 3.2% of portfolio, Reduce −0.4%
- 2023 Q1: 575,785 shares, $12M, 3.7% of portfolio, Add +20.5%
- 2023 Q2: 512,285 shares, $14M, 3.7% of portfolio, Reduce −11.0%
- 2023 Q3: 473,394 shares, $13M, 4.1% of portfolio, Reduce −7.6%
- 2023 Q4: 511,894 shares, $15M, 3.5% of portfolio, Add +8.1%
- 2024 Q1: 511,894 shares, $16M, 3.8% of portfolio
- 2024 Q2: 511,894 shares, $20M, 4.7% of portfolio
- 2024 Q3: 517,994 shares, $23M, 5.5% of portfolio, Add +1.2%
- 2024 Q4: 631,176 shares, $28M, 7.0% of portfolio, Add +21.9%
- 2025 Q1: 656,176 shares, $23M, 6.6% of portfolio, Add +4.0%
- 2025 Q2: 677,176 shares, $25M, 6.9% of portfolio, Add +3.2%
- 2025 Q3: 657,176 shares, $31M, 7.6% of portfolio, Reduce −3.0%
- 2025 Q4: 604,514 shares, $48M, 11.2% of portfolio, Reduce −8.0%
- 2026 Q1: 580,678 shares, $56M, 12.8% of portfolio, Reduce −3.9%
- 2026 Q2: 562,630 shares, $105M, 20.1% of portfolio, Reduce −3.1%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|